WO2003056341A3 - Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof - Google Patents
Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof Download PDFInfo
- Publication number
- WO2003056341A3 WO2003056341A3 PCT/DE2002/004708 DE0204708W WO03056341A3 WO 2003056341 A3 WO2003056341 A3 WO 2003056341A3 DE 0204708 W DE0204708 W DE 0204708W WO 03056341 A3 WO03056341 A3 WO 03056341A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- breast cancer
- peptides
- diagnosis
- patients
- cancer diseases
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10296200T DE10296200D2 (en) | 2001-12-21 | 2002-12-20 | Methods for diagnosing breast cancer, associated peptides and their uses |
AU2002365104A AU2002365104A1 (en) | 2001-12-21 | 2002-12-20 | Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10163747 | 2001-12-21 | ||
DE10163747.0 | 2001-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003056341A2 WO2003056341A2 (en) | 2003-07-10 |
WO2003056341A3 true WO2003056341A3 (en) | 2004-09-23 |
Family
ID=7710714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2002/004708 WO2003056341A2 (en) | 2001-12-21 | 2002-12-20 | Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002365104A1 (en) |
DE (1) | DE10296200D2 (en) |
WO (1) | WO2003056341A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006013013A2 (en) * | 2004-08-04 | 2006-02-09 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with protective protein for beta-galactosidase (ppgb) |
EP2454280A2 (en) * | 2009-07-14 | 2012-05-23 | Temple University Of The Commonwealth System Of Higher Education | Serum markers associated with early and other stages of breast cancer |
US8980269B2 (en) | 2009-07-14 | 2015-03-17 | Temple University Of The Commonwealth System Of Higher Education | G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker |
EP2548888B1 (en) * | 2010-03-17 | 2017-11-01 | Kagoshima University | Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5798266A (en) * | 1996-08-27 | 1998-08-25 | K-Quay Enterprises, Llc | Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer |
WO2001036470A2 (en) * | 1999-11-16 | 2001-05-25 | Matritech, Inc. | Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
WO2002059377A2 (en) * | 2001-01-24 | 2002-08-01 | Protein Design Labs | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
-
2002
- 2002-12-20 DE DE10296200T patent/DE10296200D2/en not_active Expired - Fee Related
- 2002-12-20 AU AU2002365104A patent/AU2002365104A1/en not_active Abandoned
- 2002-12-20 WO PCT/DE2002/004708 patent/WO2003056341A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5798266A (en) * | 1996-08-27 | 1998-08-25 | K-Quay Enterprises, Llc | Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer |
WO2001036470A2 (en) * | 1999-11-16 | 2001-05-25 | Matritech, Inc. | Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
WO2002059377A2 (en) * | 2001-01-24 | 2002-08-01 | Protein Design Labs | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
Non-Patent Citations (4)
Title |
---|
LAPOINTE JACQUES ET AL: "Identification and cloning of a novel androgen-responsive gene, uridine diphosphoglucose dehydrogenase, in human breast cancer cells", ENDOCRINOLOGY, vol. 140, no. 10, October 1999 (1999-10-01), pages 4486 - 4493, XP002263718, ISSN: 0013-7227 * |
WATKINS B ET AL: "DETECTION OF EARLY-STAGE CANCER BY SERUM PROTEIN ANALYSIS", AMERICAN LABORATORY, INTERNATIONAL SCIENTIFIC COMMUNICATIONS, SHELTON,, US, vol. 33, no. 12, June 2001 (2001-06-01), pages 32 - 36, XP008015348, ISSN: 0044-7749 * |
WATKINS B ET AL: "IDENTIFICATION OF SERUM NUCLEAR MATRIX PROTEIN MARKERS OF BREAST CANCER USING SURFACE ENHANCED LASER DESORPTION-IONIZATION (SELDI) MASS SPECTROSCOPY", BREAST CANCER RESEARCH AND TREATMENT, NIJHOFF, BOSTON, US, vol. 64, no. 1, November 2000 (2000-11-01), pages 98, XP001001191, ISSN: 0167-6806 * |
WATKINS B ET AL: "SURFACE ENHANCED LASER DESORPTION-IONIZATION (SELDI) MASS SPECTROSCOPY IN THE DISCOVERY OF SERUM MARKERS FOR BREAST CANCER", TUMOR BIOLOGY, KARGER, BASEL, CH, vol. 21, no. SUPPL 1, September 2000 (2000-09-01), pages 35, XP001001193, ISSN: 1010-4283 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002365104A8 (en) | 2003-07-15 |
DE10296200D2 (en) | 2004-11-04 |
AU2002365104A1 (en) | 2003-07-15 |
WO2003056341A2 (en) | 2003-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002059604A3 (en) | Diagnosis and treatment of multiple sclerosis | |
DE69922261D1 (en) | MONOCLONAL ANTIBODIES, ANTIGENS AND DIAGNOSIS AND THERAPY OF VICIOUS DISEASES | |
WO2002054081A3 (en) | Proteins, genes and their use for diagnosis and treatment of kidney response | |
WO1998045322A3 (en) | Diagnosis method and reagents | |
DE60126592D1 (en) | METHODS, COMPOSITIONS AND KITS FOR IDENTIFYING AND MONITORING BREAST CANCER | |
WO2001000828A3 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
WO2001040269A3 (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
WO2000060076A3 (en) | Compositions for the treatment and diagnosis of breast cancer and methods for their use | |
WO2004037999A3 (en) | A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same | |
WO2004058044A3 (en) | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor | |
HK1077602A1 (en) | Use of nucleic acids in preparation of a diagnostic agent for evaluating a disease condition in a patient | |
WO2001075454A3 (en) | Diagnosis and treatment of alzheimer's disease | |
EP1870466A3 (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
HUP0400284A2 (en) | Recombinant tumor specific antibody and use thereof | |
WO2003087831A3 (en) | Proteins involved in breast cancer | |
WO2003070894A3 (en) | A non-invasive diagnostic test utilizing histone modification markers | |
WO2003048775A3 (en) | Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases | |
WO2003016464A3 (en) | Cancer specific oligosaccharide sequences and use thereof | |
WO2005056585A3 (en) | Sars coronavirus s proteins and uses thereof | |
WO2003028543A3 (en) | Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease | |
WO2003056341A3 (en) | Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof | |
WO2004071273A3 (en) | Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus | |
WO2000078960A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
WO2005037999A3 (en) | Treatment of cancer using antibodies to lrrc15 | |
WO2001057207A3 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REF | Corresponds to |
Ref document number: 10296200 Country of ref document: DE Date of ref document: 20041104 Kind code of ref document: P |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10296200 Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |